Clinical features of anti-mitochondrial M2 antibody-positive myositis: Case series of 17 patients

被引：0
|
作者：
Nagai, A. [1 ]
Nagai, T. [1 ]
Yaguchi, H. [1 ]
Fujii, S. [2 ]
Horiuchi, K. [2 ]
Ura, S. [3 ]
Shirai, S. [1 ]
Iwata, I. [1 ]
Matsushima, M. [1 ]
Anzai, T. [1 ]
Yabe, I. [1 ]
机构：
[1] Hokkaido Univ, Sapporo, Hokkaido, Japan
[2] Hakodate City Hosp, Hakodate, Hokkaido, Japan
[3] Japanese Red Cross Asahikawa Hosp, Asahikawa, Hokkaido, Japan
来源：
NEUROMUSCULAR DISORDERS | 2022年 / 32卷
关键词：
D O I：
10.1016/j.nmd.2022.07.176
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
VP.45
引用
收藏
页码：S84 / S84
页数：1
相关论文
共 50 条
  • [21] Pathological findings with vacuoles in anti-mitochondrial antibody-positive inflammatory myopathy
    Yuanchong Chen
    Wei Zhang
    He Lv
    Zhaoxia Wang
    Hongjun Hao
    Yun Yuan
    Yiming Zheng
    BMC Musculoskeletal Disorders, 25
  • [22] Morphological features of mitochondria in anti-mitochondrial antibodies-positive myositis
    Nagasaka, T.
    Hata, T.
    Ichinose, Y.
    Kho, K.
    Yamashiro, N.
    Tsuchiya, M.
    Takaki, R.
    Shindo, K.
    Takiyama, Y.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 821 - 821
  • [23] Anti-mitochondrial M2 Antibodies and Myopathy
    Finsterer, Josef
    Zarrouk-Mahjoub, Sinda
    INTERNAL MEDICINE, 2018, 57 (08) : 1187 - 1187
  • [24] Myositis with Anti-mitochondrial Antibody Type 2 with Diplopia and Ptosis
    Nomura, Taichi
    Iwami, Kosuke
    Nagai, Azusa
    Tsuzaka, Kazufumi
    Yabe, Ichiro
    INTERNAL MEDICINE, 2021, 60 (20) : 3325 - 3328
  • [25] Clinical and laboratory manifestations in anti-mitochondrial type 5 antibody positive patients
    Andrejevic, S.
    Bonaci-Nikolic, B.
    Bukilica-Sefik, M.
    Petrovic, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : A18 - A18
  • [26] Anti-mitochondrial M2 Antibodies and Myopathy: Reply
    Konishi, Hiroki
    Fukuzawa, Koji
    Mori, Shumpei
    Satomi-Kobayashi, Seimi
    Kiuchi, Kunihiko
    Suzuki, Atsushi
    Akita, Tomomi
    Yano, Yoshihiko
    Yoshida, Akihiro
    Hirata, Ken-ichi
    INTERNAL MEDICINE, 2018, 57 (08) : 1189 - 1189
  • [27] Survival of anti-mitochondrial antibody-positive and -negative primary biliary cirrhosis patients on ursodeoxycholic acid treatment
    Koulentaki, M
    Moscandrea, J
    Dimoulios, P
    Chatzicostas, C
    Kouroumalis, EA
    DIGESTIVE DISEASES AND SCIENCES, 2004, 49 (7-8) : 1190 - 1195
  • [28] Survival of Anti-Mitochondrial Antibody-Positive and -Negative Primary Biliary Cirrhosis Patients on Ursodeoxycholic Acid Treatment
    Meri Koulentaki
    Joanna Moscandrea
    Philipos Dimoulios
    Costas Chatzicostas
    Elias A. Kouroumalis
    Digestive Diseases and Sciences, 2004, 49 : 1190 - 1195
  • [29] Histopathologic comparison of anti-mitochondrial antibody-positive primary biliary cirrhosis and autoimmune cholangiopathy
    Watanabe, S
    Deguchi, A
    Uchida, N
    Kurokohchi, K
    Arima, K
    Nishioka, M
    Hasui, H
    HEPATOLOGY RESEARCH, 2001, 19 (01) : 41 - 51
  • [30] Positive rate of anti-mitochondrial m2 antibody and anti-soluble liver antigen antibody in the patients with primary biliary cholangitis and autoimmune hepatitis in south korea
    Choi, Jae Kyun
    Jang, Boo-Ok
    Lee, Kyunghan
    Kim, Si Ho
    Choi, Gwang Hyeon
    Jang, Eun Sun
    Kim, Jin-Wook
    Jeong, Sook-Hyang
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 356 - 356
12345